• DMPK Gene Analysis for Myotonic Dystrophy Type I (DM1)
  • Subtelomeric Region Anomalies, FISH, Amniotic Fluid
  • Epstein-Barr Virus (EBV) Nuclear Antigen (EBNA) Antibody, IgG
  • Clobazam, Serum
  • U2 Small Nuclear RNA Auxiliary Factor 1 (U2AF1) Gene Mutation Analysis
  • 11-Deoxycortisol, Quantitative, Serum
  • Multiple Sulfatase Deficiency, Gene Mutation Analysis
  • Adenovirus Antigen Detection
  • Clostridium difficile (C. Diff), Culture
  • Leukemia/Lymphoma Immunophenotyping by Flow Cytometry, Tissue
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS
Medical Test

Methodology
Access to Amyotrophic Lateral Sclerosis Gene Mutation Panel, NGS is restricted.
Loading...